Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group

Demirkan, FG; Ulu, K; Ozturk, K; Karadas, SG; Ozdel, S; Sonmez, HE; Cakmak, F; Demir, F; Sozeri, B; Ayaz, NA

Ayaz, NA (通讯作者),Istanbul Univ, Istanbul Sch Med, Dept Pediat Rheumatol, Istanbul, Fatih, Turkey.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2022; 22 (2): 197

Abstract

Objectives To review the real-life data, to provide an input to the literature concerning treatment of juvenile idiopathic arthritis (JIA) with adalim......

Full Text Link